Home LiteratureArticle Details
PMID: 3486158 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media.

Infection and immunity ·Vol. 52 ·No. 2 ·1986-05-00 ·Pages 572-8

Barenkamp SJ

Abstract

The chinchilla experimental model of otitis media was used to examine the importance of serum antibodies in protection against disease caused by nontypable Haemophilus influenzae. An immune serum pool was prepared by immunizing chinchillas with killed bacterial cells of nontypable H. influenzae 3245. Pooled preimmune or immune serum from these immunized animals was administered intravenously to a group of nonimmune chinchillas 1 day before intrabullar challenge with strain 3245. Of 5 animals receiving preimmune serum, 5 developed otitis media compared with 0 of 10 animals receiving immune serum (P = 0.008). The immune serum pool contained antibodies directed against both surface-exposed outer membrane proteins and lipopolysaccharide (LPS). The 39-kilodalton major outer membrane protein was the immunodominant surface protein. Anti-LPS antibodies were removed from the immune serum pool by affinity chromatography, and affinity-purified anti-LPS antibodies were recovered. Immune serum, immune serum absorbed of LPS antibodies, or affinity-purified LPS antibodies were then administered to another group of experimental animals 1 day before bacterial challenge. Of four animals that received the affinity-purified LPS antibodies, four developed otitis compared with zero of four animals that received the immune serum or zero of four animals that received the LPS-absorbed immune serum (P = 0.028). These studies indicate that passive immunization with immune serum is protective in experimental nontypable H. influenzae otitis media and that bacterial outer membrane proteins may be the principal targets of protective antibody.

MeSH Terms
Animals Antibodies, Bacterial/immunology Antibody Specificity Antigens, Bacterial/immunology Antigens, Surface/immunology Bacterial Outer Membrane Proteins/immunology Chemical Precipitation Chinchilla Haemophilus influenzae/immunology Humans Immunization, Passive Immunoglobulin G/immunology Immunoglobulin M/immunology Lipopolysaccharides/immunology Otitis Media/immunology,prevention & control
Chemicals
Antibodies, Bacterial Antigens, Bacterial Antigens, Surface Bacterial Outer Membrane Proteins Immunoglobulin G Immunoglobulin M Lipopolysaccharides
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Barenkamp S J
References (29)
29 references, click to expand
  1. Otitis media: a clinical and bacteriological correlation.
    Pediatrics. 1970 Jan;45(1):29-35 PMID: 4903112
  2. Antigenic heterogeneity of outer membrane proteins of nontypable Haemophilus influenzae is a basis for a serotyping system.
    Infect Immun. 1985 Oct;50(1):15-21 PMID: 3876283
  3. Experimental otitis media due to Streptococcus pneumoniae: immunopathogenic response in the chinchilla.
    J Infect Dis. 1976 Dec;134(6):595-604 PMID: 12236
  4. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection.
    J Clin Invest. 1977 Nov;60(5):1149-58 PMID: 409733
  5. A simplification of the protein assay method of Lowry et al. which is more generally applicable.
    Anal Biochem. 1977 Dec;83(2):346-56 PMID: 603028
  6. Microbiology of recurrent and chronic otitis media with effusion.
    J Pediatr. 1978 Nov;93(5):739-43 PMID: 30809
  7. Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens.
    J Clin Invest. 1980 Apr;65(4):885-91 PMID: 6153662
  8. Surgical treatment of recurrent perilymph fistula with anacusis.
    Ann Otol Rhinol Laryngol. 1980 Mar-Apr;89(2 Pt 1):121-3 PMID: 7369644
  9. Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae.
    J Pediatr. 1980 Sep;97(3):364-9 PMID: 6967963
  10. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy.
    J Pediatr. 1981 Apr;98(4):537-9 PMID: 6970803
  11. The pathogenesis of pneumococcal otitis media in chinchillas and the efficacy of vaccination in prophylaxis.
    Rev Infect Dis. 1981 Mar-Apr;3(2):342-53 PMID: 7256090
  12. Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production.
    J Infect Dis. 1981 Aug;144(2):101-6 PMID: 6974204
  13. Detection of antibody-accessible proteins on the cell surface of Haemophilus influenzae type b.
    Infect Immun. 1981 Sep;33(3):950-3 PMID: 6974700
  14. Human antibody responses to lipopolysaccharide after meningitis due to Haemophilus influenzae type b.
    J Infect Dis. 1982 Feb;145(2):181-90 PMID: 6976394
  15. Outer membrane protein and biotype analysis of pathogenic nontypable Haemophilus influenzae.
    Infect Immun. 1982 May;36(2):535-40 PMID: 6979511
  16. Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. Roles of blocking antibody and gonococcal outer membrane proteins.
    J Clin Invest. 1982 Jul;70(1):157-67 PMID: 6806319
  17. Experimental otitis media in chinchillas. I. Baseline immunological investigation.
    Ann Otol Rhinol Laryngol Suppl. 1982 May-Jun;93:1-8 PMID: 6807183
  18. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease.
    Infect Immun. 1982 Jul;37(1):82-8 PMID: 6980838
  19. Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae.
    Infect Immun. 1983 Jan;39(1):297-304 PMID: 6600447
  20. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.
    J Bacteriol. 1983 Apr;154(1):269-77 PMID: 6187729
  21. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.
    J Bacteriol. 1983 Aug;155(2):831-8 PMID: 6409884
  22. Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.
    J Clin Invest. 1983 Aug;72(2):677-84 PMID: 6603479
  23. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
    Infect Immun. 1983 Oct;42(1):257-63 PMID: 6604698
  24. Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae.
    J Infect Dis. 1983 Sep;148(3):492-9 PMID: 6604761
  25. Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens.
    J Infect Dis. 1985 Feb;151(2):273-9 PMID: 3871464
  26. Transmembrane permeability channels across the outer membrane of Haemophilus influenzae type b.
    J Bacteriol. 1985 Jun;162(3):918-24 PMID: 2987194
  27. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    J Clin Invest. 1985 May;75(5):1645-58 PMID: 3873475
  28. Coprecipitation of lipopolysaccharide and the 39,000-molecular-weight major outer membrane protein of Haemophilus influenzae type b by lipopolysaccharide-directed monoclonal antibody.
    Infect Immun. 1985 Sep;49(3):819-27 PMID: 3875563
  29. The immune response to acute otitis media in children. II. Serum and middle ear fluid antibody in otitis media due to Haemophilus influenza.
    J Infect Dis. 1975 Dec;132(6):685-8 PMID: 1104722
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1986-05-00
Pages
572-8
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC261039
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]